4//SEC Filing
NAVIDEA BIOPHARMACEUTICALS, INC. 4
Accession 0001225208-14-002867
CIK 0000810509operating
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 10:13 AM ET
Size
5.1 KB
Accession
0001225208-14-002867
Insider Transaction Report
Form 4
Reininger Cornelia
SVP & Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2014-01-28+143,000→ 143,000 totalExercise: $1.77Exp: 2024-01-28→ Common Stock (143,000 underlying)
Footnotes (1)
- [F1]Option vests 25% per year beginning on the first anniversary of the date of grant.
Documents
Issuer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK 0000810509
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000810509
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 10:13 AM ET
- Size
- 5.1 KB